Vestal Point Capital’s Soleno Therapeutics SLNO Stock Holding History

Vestal Point Capital’s Portfolio SLNO Stock Details SLNO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.4M	Buy
2025 Q1	–	Sell
2024 Q4	$47.6M	Buy
2024 Q3	$36.4M	Sell
2024 Q2	$49M	Sell
2024 Q1	$53.5M	Sell
2023 Q4	$52.3M	Buy